GBP10.10
0.49% today
London, Jun 10, 05:37 pm CET
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Indivior Stock price

GBP10.10
+1.65 19.46% 1M
+1.02 11.23% 6M
-0.14 1.37% YTD
-3.04 23.14% 1Y
+6.85 210.77% 5Y
-1.02 9.20% 10Y
+2.92 40.68% 20Y
London, Closing price Tue, Jun 10 2025
-0.05 0.49%
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Key metrics

Market capitalization GBP1.30b
Enterprise Value GBP1.27b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 13.00
EV/Sales (TTM) EV/Sales 0.83
P/S ratio (TTM) P/S ratio 0.85
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 83.27%
Revenue (TTM) Revenue GBP1.52b
EBIT (operating result TTM) EBIT GBP393.19m
Free Cash Flow (TTM) Free Cash Flow GBP97.38m
Cash position GBP275.16m
EPS (TTM) EPS GBP-0.32
P/E forward 10.41
P/S forward 1.71
EV/Sales forward 1.66
Short interest 293.00%
Show more

Is Indivior a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,838 stocks worldwide.

Indivior Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Indivior forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a Indivior forecast:

Buy
100%

Financial data from Indivior

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,520 1,520
83% 83%
100%
- Direct Costs 243 243
71% 71%
16%
1,276 1,276
86% 86%
84%
- Selling and Administrative Expenses 747 747
78% 78%
49%
- Research and Development Expense 131 131
66% 66%
9%
412 412
94% 94%
27%
- Depreciation and Amortization 18 18
19% 19%
1%
EBIT (Operating Income) EBIT 393 393
107% 107%
26%
Net Profit -41 -41
1,199% 1,199%
-3%

In millions GBP.

Don't miss a Thing! We will send you all news about Indivior directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Head office United Kingdom
CEO Joseph Ciaffoni
Employees 1,041
Founded 2014
Website www.indivior.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today